推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

CELLULAR ONCOLOGY

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 最新评论:暂无评论!


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

00 : 00 : 00

按研究方向查看:


CELLULAR ONCOLOGY期刊基本信息Hello,您是该期刊的第33243位访客

基本信息 登录收藏
期刊名字CELLULAR ONCOLOGYCELLULAR ONCOLOGY

CELL ONCOL
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.3
50人评分
我要评分

声誉
8.6

影响力
6.3

速度
7.0

期刊ISSN2211-3428
微信扫码收藏此期刊
E-ISSN2211-3436
2022-2023最新影响因子
(数据来源于搜索引擎)
6.6 点击查看影响因子趋势图
实时影响因子 截止2023年12月27日:4.338
2022-2023自引率1.50%点击查看自引率趋势图
五年影响因子6.1
h-index 31
CiteScore
CiteScoreSJRSNIPCiteScore排名
10.401.4081.116
学科分区排名百分位
大类:Medicine
小类:Oncology
Q146 / 366
大类:Medicine
小类:Molecular Medicine
Q128 / 171
大类:Medicine
小类:Cancer Research
Q138 / 214

期刊简介The Official Journal of the International Society for Cellular Oncology
Focuses on translational research
Addresses the conversion of cell biology to clinical applications
Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions.

A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology forms a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologists and other clinicians involved in the management of cancer patients.
In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations.
期刊官方网站https://www.springer.com/13402
期刊投稿网址https://www.editorialmanager.com/ceon
作者指南网址https://www.springer.com/13402/submission-guidelines
期刊语言要求Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CELLULAR ONCOLOGY的语言要求,还能让CELLULAR ONCOLOGY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CELLULAR ONCOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ
出版商Springer Netherlands
涉及的研究方向ONCOLOGY-CELL BIOLOGY
出版国家或地区NETHERLANDS
出版语言English
出版周期6 issues per year
出版年份2011
年文章数 104点击查看年文章数趋势图
Gold OA文章占比27.70%
研究类文章占比:
文章 ÷(文章 + 综述)
81.73%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:CELL BIOLOGY
类别:SCIE
Q253/191
学科:ONCOLOGY
类别:SCIE
Q150/241
学科:PATHOLOGY
类别:SCIE
Q18/76
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区2区1区
CELL BIOLOGY
细胞生物学
1区4区2区
PATHOLOGY
病理学
4区2区2区
ONCOLOGY
肿瘤学
4区4区3区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区3区
PATHOLOGY
病理学
1区4区1区
CELL BIOLOGY
细胞生物学
3区3区2区
ONCOLOGY
肿瘤学
1区3区2区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区3区
ONCOLOGY
肿瘤学
2区1区2区
PATHOLOGY
病理学
4区2区2区
CELL BIOLOGY
细胞生物学
3区3区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2211-3428%5BISSN%5D
平均审稿速度网友分享经验:
平均12月
平均录用比例网友分享经验:
约25%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在CELLULAR ONCOLOGY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 CELLULAR ONCOLOGY期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CELLULAR ONCOLOGY中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CELLULAR ONCOLOGY上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Journal of Extracellular Vesicles023.90
    AGING CELL11315.00
    Science Signaling12812.50
    Cell Death Discovery06.60
    Stem Cell Reports5511.60
    Frontiers in Cell and Developmental Biology06.30
    Stem Cell Reviews and Reports618.80
    Analytical Cellular Pathology184.70
    Cell Adhesion & Migration06.70
    BMC Molecular and Cell Biology04.60
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE591097
    BIOMATERIALS505120
    Journal of Materials Chemistry B452173
    BIOMEDICINE & PHARMACOTHERAPY450794
    Frontiers in Pharmacology439508
    Frontiers in Immunology409016
    COLLOIDS AND SURFACES B-BIOINTERFACES397798
    JOURNAL OF ETHNOPHARMACOLOGY395616
    Frontiers in Oncology375652
    Acta Biomaterialia368384
  •  

    CELLULAR ONCOLOGY CELLULAR ONCOLOGY
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Comprehensive analysis of clinical prognostic features and tumor microenvironment landscape of CD11b(+)CD64(+) patients with acute myeloid leukemia

    Author: Wang, Qian; Zhang, Nan; Liu, Li; Ma, Linlu; Tan, Yuxin; Liu, Xiaoyan; Wu, Jinxian; Chen, Guopeng; Li, Xinqi; Liang, Yuxing; Zhou, Fuling
    Journal: CELLULAR ONCOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s13402-023-00808-7
        PubMed      DOI
    2.In vivo study revealed pro-tumorigenic effect of CMTM3 in hepatocellular carcinoma involving the regulation of peroxisome proliferator-activated receptor gamma (PPAR gamma)

    Author: Wang, Jiahui; Chu, Hongjin; Wang, Zhixin; Wang, Xuebo; Liu, Xuexia; Song, Zhan; Liu, Fujun
    Journal: CELLULAR ONCOLOGY. 2023; Vol. 46, Issue 1, pp. 49-64. DOI: 10.1007/s13402-022-00733-1
        PubMed      DOI
    3.Research advances and treatment perspectives of pancreatic adenosquamous carcinoma

    Author: Zhang, Wen; Zhang, Jing; Liang, Xijun; Ding, Jin
    Journal: CELLULAR ONCOLOGY. 2023; Vol. 46, Issue 1, pp. 1-15. DOI: 10.1007/s13402-022-00732-2
        PubMed      DOI
    4.FUT8 is regulated by miR-122-5p and promotes malignancies in intrahepatic cholangiocarcinoma via PI3K/AKT signaling

    Author: Chen, Fanghua; Li, Yin; Aye, Ling; Wu, Yingcheng; Dong, Liangqing; Yang, Zijian; Gao, Qiang; Zhang, Shu
    Journal: CELLULAR ONCOLOGY. 2023; Vol. 46, Issue 1, pp. 79-91. DOI: 10.1007/s13402-022-00736-y
        PubMed      DOI
    5.PKMYT1 inhibits lung adenocarcinoma progression by abrogating AKT1 activity

    Author: Wang, Shuang; Liu, Ximeng; Zhou, Ting; Li, Jinling; Lin, Ying; Zhou, Anni; Huang, Jiamin; Zhao, Jingjing; Cai, Junchao; Cai, Xiuyu; Huang, Yongbo; Li, Xu
    Journal: CELLULAR ONCOLOGY. 2023; Vol. 46, Issue 1, pp. 195-209. DOI: 10.1007/s13402-022-00744-y
        PubMed      DOI
    6.Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment

    Author: Zhu, Yu-Heng; Zheng, Jia-Hao; Jia, Qin-Yuan; Duan, Zong-Hao; Yao, Hong-Fei; Yang, Jian; Sun, Yong-Wei; Jiang, Shu-Heng; Liu, De-Jun; Huo, Yan-Miao
    Journal: CELLULAR ONCOLOGY. 2023; Vol. 46, Issue 1, pp. 17-48. DOI: 10.1007/s13402-022-00741-1
        PubMed      DOI
    7.TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4(+)Foxp3(+) regulatory T cells

    Author: He, Tianzhen; Chen, Yibo; Yang, De; Islam, Md Sahidul; Chou, Chon-Kit; Liu, Jiarui; Faustman, Denise L.; Oppenheim, Joost J.; Chen, Xin
    Journal: CELLULAR ONCOLOGY. 2023; Vol. 46, Issue 1, pp. 167-177. DOI: 10.1007/s13402-022-00742-0
        PubMed      DOI
    8.IDH2, a novel target of OGT, facilitates glucose uptake and cellular bioenergy production via NF-kappa B signaling to promote colorectal cancer progression

    Author: He, Xiaoli; Wu, Nan; Li, Renlong; Zhang, Haohao; Zhao, Yu; Nie, Yongzhan; Wu, Jing
    Journal: CELLULAR ONCOLOGY. 2023; Vol. 46, Issue 1, pp. 145-164. DOI: 10.1007/s13402-022-00740-2
        PubMed      DOI
    9.Single cell profiling of gamma delta hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression

    Author: Song, Wei; Zhang, Haixi; Yang, Fan; Nakahira, Kiichi; Wang, Cheng; Shi, Keqian; Zhang, Ruoyu
    Journal: CELLULAR ONCOLOGY. 2023; Vol. 46, Issue 1, pp. 211-226. DOI: 10.1007/s13402-022-00745-x
        PubMed      DOI
    10.Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis

    Author: Xu, Ying; Luan, Guangchao; Li, Zhongchao; Liu, Ziming; Qin, Guangyang; Chu, Yifu
    Journal: CELLULAR ONCOLOGY. 2023; Vol. 46, Issue 2, pp. 251-264. DOI: 10.1007/s13402-022-00746-w
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity065.50
    Living Reviews in Relativity7565.50
    JOURNAL OF TRAVEL MEDICINE5119.60
    Military Medical Research030.10
    Advanced Composites and Hybrid Materials016.90
    INTERNATIONAL JOURNAL OF COMPUTER VISION17222.50
    Eurosurveillance9027.70
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE715.70
    Small Structures00.00
    Trends in Chemistry032.10


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共0条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451